Andrea Spolcova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tau/DDX6 interaction increases microRNA activity.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: March 11, 2018
Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring.
Journal: Journal of physiology and pharmacology : an official journal of the Polish Physiological Society
Published: November 04, 2015
Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity.
Journal: Journal of Alzheimer's disease : JAD
Published: January 28, 2015
Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration.
Journal: International journal of obesity (2005)
Published: August 29, 2014
Changes in FGF21 serum concentrations and liver mRNA expression in an experimental model of complete lipodystrophy and insulin-resistant diabetes.
Journal: Physiological research
Published: June 09, 2014
Hypooxytocinaemia in obese Zucker rats relates to oxytocin degradation in liver and adipose tissue.
Journal: The Journal of endocrinology
Published: January 07, 2014
Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats.
Journal: BMC neuroscience
Published: September 17, 2013
Ghrelin agonist JMV 1843 increases food intake, body weight and expression of orexigenic neuropeptides in mice.
Journal: Physiological research
Published: April 18, 2013
Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration.
Journal: Brain research
Published: September 12, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026